{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:27:45Z","timestamp":1773235665224,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.drugalcdep.2010.11.016","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T09:47:06Z","timestamp":1293011226000},"page":"233-237","source":"Crossref","is-referenced-by-count":11,"title":["Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy"],"prefix":"10.1016","volume":"116","author":[{"given":"Lynn E.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nickolas","family":"Zaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Cioe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela A.","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Hedgis","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0005","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1002\/hep.510260711","article-title":"Epidemiology of hepatitis C","volume":"26","author":"Alter","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2893.2006.00749.x","article-title":"Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons","volume":"13","author":"Alvarez","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/jhep.2001.25882","article-title":"Treatment of hepatitis C infection in injection drug users","volume":"34","author":"Backmund","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0020","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis\u2014an update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0025","series-title":"Manual for Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.23020","article-title":"Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"50","author":"Berenguer","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/QAI.0b013e3181e36420","article-title":"Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis","volume":"55","author":"Bhattacharya","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0045","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1572-0241.2008.02065.x","article-title":"Efficacy and safety of peginterferon alfa-2a\/ribavirin in methadone maintenance patients: randomized comparison of direct observed therapy and self-administration","volume":"103","author":"Bonkovsky","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1310\/hct1001-25","article-title":"Rates of HCV treatment eligibility among HCV-monoinfected and HCV\/HIV-coinfected patients in tertiary care referral centers","volume":"10","author":"Butt","year":"2009","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0055","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMra023160","article-title":"Drug addiction","volume":"349","author":"Cami","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0060","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.292.23.2839","article-title":"Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial","volume":"292","author":"Carrat","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa032653","article-title":"Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons","volume":"351","author":"Chung","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2010.11.016_bib0070","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1086\/421404","article-title":"Directly observed therapy for the management of HIV-infected patients in a methadone program","volume":"38","author":"Conway","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000049487","article-title":"Treatment of chronic hepatitis C in injecting drug users: 5 year's follow-up","volume":"8","author":"Dalgard","year":"2002","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM200107193450312","article-title":"Treatment of chronic hepatitis C in active drug users","volume":"345","author":"Davis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0085","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.qai.0000131932.21612.49","article-title":"Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection","volume":"37","author":"Fishbein","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/344907","article-title":"Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment","volume":"36","author":"Fleming","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0095","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1086\/374049","article-title":"Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection","volume":"36","author":"Fultz","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0100","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0105","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1440-1746.2007.05032.x","article-title":"Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users","volume":"22","author":"Grebely","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2893.2009.01080.x","article-title":"Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents","volume":"16","author":"Grebely","year":"2009","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/600304","article-title":"Hepatitis C treatment for injection drug users: a review of the available evidence","volume":"49","author":"Hellard","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0120","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.2008.648","article-title":"Methadone maintenance 4 decades later: thousands of lives saved but still controversial","volume":"300","author":"Kleber","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0125","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra065142","article-title":"Viral hepatitis in HIV infection","volume":"356","author":"Koziel","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2008.09.009","article-title":"Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program","volume":"37","author":"Litwin","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.20279","article-title":"A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance","volume":"40","author":"Mauss","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v20n01_03","article-title":"Hepatitis C in methadone maintenance patients: prevalence and public policy implications","volume":"20","author":"McCarthy","year":"2001","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2008","journal-title":"J. Community Health"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0150","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/QAD.0b013e32801086da","article-title":"Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic","volume":"20","author":"Mehta","year":"2006","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.drugalcdep.2010.11.016_bib0155","first-page":"1","article-title":"NIH concenus statement on management of hepatitis C: 2002","volume":"19","author":"National Institute of Health","year":"2002","journal-title":"NIH Consens. State Sci. Statements"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0160","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1360-0443.2008.02188.x","article-title":"Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients","volume":"103","author":"Novick","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J069v21n04_06","article-title":"Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment","volume":"21","author":"Piccolo","year":"2002","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0170","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jmv.21781","article-title":"Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with HIV","volume":"82","author":"Rachline","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.qai.0000148535.97081.72","article-title":"Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin","volume":"38","author":"Rauch","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jhep.2003.50031","article-title":"Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups","volume":"37","author":"Schaefer","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0185","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/339042","article-title":"Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group","volume":"34","author":"Sherman","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/135965350701200402","article-title":"Premature treatment discontinuation in HIV\/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin","volume":"12","author":"Soriano","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0195","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-138-3-200302040-00012","article-title":"Hepatitis C in the HIV-Infected Person","volume":"138","author":"Sulkowski","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0205","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/MEG.0b013e3281bcb8d8","article-title":"Adherence to hepatitis C treatment in recovering heroin users maintained on methadone","volume":"19","author":"Sylvestre","year":"2007","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0210","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jurban\/jth153","article-title":"Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care","volume":"81","author":"Sylvestre","year":"2004","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drugpo.2007.01.010","article-title":"Integrating HCV services for drug users: a model to improve engagement and outcomes","volume":"18","author":"Sylvestre","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0220","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1097\/00002030-200208160-00024","article-title":"Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV\/hepatitis C virus co-infected individuals","volume":"16","author":"Taylor","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0225","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients","volume":"351","author":"Torriani","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2010.11.016_bib0230","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/apc.2009.0049","article-title":"Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection","volume":"23","author":"Wagner","year":"2009","journal-title":"AIDS Patient Care STDS"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871610004126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871610004126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T15:44:28Z","timestamp":1685893468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871610004126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":46,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0376871610004126"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.11.016","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}